Friday, April 11, 2014 1:56:11 PM
Thanks for your comments Suberizdwrx,
I appreciate any info people share that offers insight into the game.
So, from a top zone at 2.75 , a 20 % pullback takes us to the 2.20 price point, which happens also to be a big support point on the chart.
It might be overly optimistic to expect a fall to 1.95. but stair steps at a time.... this short play was a good trade already, and beyond the 2.20 area is just being greedy.
BUT the bigger target low is 2.13.....ad IF that gets run through, we could possibly see 2 dollars as the bargain to buy.
Buyers will likely start stepping in ahead of 2 dollars, maybe 2.05 sort of thing.
Suberizedwrx, your analysis of PVCT is not really very correct. The 6 dollar surge was a severe pump and dump operation, to start with, but if youre simply playing a trade,its a decent short trade from 2.75 to 2.15. well done.
I appreciate any info people share that offers insight into the game.
So, from a top zone at 2.75 , a 20 % pullback takes us to the 2.20 price point, which happens also to be a big support point on the chart.
It might be overly optimistic to expect a fall to 1.95. but stair steps at a time.... this short play was a good trade already, and beyond the 2.20 area is just being greedy.
BUT the bigger target low is 2.13.....ad IF that gets run through, we could possibly see 2 dollars as the bargain to buy.
Buyers will likely start stepping in ahead of 2 dollars, maybe 2.05 sort of thing.
Suberizedwrx, your analysis of PVCT is not really very correct. The 6 dollar surge was a severe pump and dump operation, to start with, but if youre simply playing a trade,its a decent short trade from 2.75 to 2.15. well done.
Recent PVCT News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 01:19:25 AM
- Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee • GlobeNewswire Inc. • 04/20/2026 10:09:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 07:30:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 09:07:00 PM
- Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 03:46:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 04:43:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 01:19:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 04:15:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 07:20:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 07:05:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 06:49:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 03:22:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 11:24:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 08:30:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2026 09:22:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 04:28:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:40 AM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 12/08/2025 02:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 05:39:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 06:47:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2025 05:54:42 PM
